5 completed, 1 no longer available. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow AMG-714: new trials by email Literature Review of AMG-714 trials Research Report on AMG-714
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of AMG 714 for Vitiligo AMG 714, Placebo, nbUVB phototherapy - Vitiligo | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2020-12-11 | 2026-04-21 |
| Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease AMG 714, Placebo - Type II Refractory Celiac Disease (RCD-II), In-situ Small Bowel T-cell Lymphoma | Phase 2 | Completed | Amgen | 28 | 2016-04-13 | 2019-12-27 |
| A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease AMG 714, Placebo, Placebo Gluten Challenge - Celiac Disease | Phase 2 | Completed | Amgen | 64 | 2016-04-13 | 2019-12-03 |
| AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects AMG 714 - Psoriasis | Phase 2 | Completed | Amgen | 22 | 2007-03-01 | 2016-01-20 |
| Phase 2 AMG 714 in Rheumatoid Arthritis AMG 714 - Rheumatoid Arthritis | Phase 2 | Completed | Amgen | 180 | 2002-12-01 | 2007-12-28 |
| AMG 714 Expanded Access Program AMG 714 - Celiac Disease | No longer available | Amgen | 2025-05-04 |
Celiac Disease (2) · Arthritis, Rheumatoid (1) · Psoriasis (1) · Vitiligo (1)
Amgen (5) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Finland (2) · United States (2) · France (1) · Netherlands (1) · Spain (1)
PMID 31494096, PMID 31494097, PMID 41039829
2015 (2)